Try our Advanced Search for more refined results
Intellectual Property
-
May 22, 2025
Fed. Circ. Ruling Will Spark More Patent Damages Fights
The full Federal Circuit's decision Wednesday ordering a new trial in a patent case against Google LLC and finding the plaintiff's damages expert unreliable is likely to lead to greater scrutiny of patent damages testimony and more attempts to get it thrown out, attorneys say.
-
May 22, 2025
Training LLMs Is OK, Pirating Isn't: Anthropic Judge Tips Hand
A California federal judge considering writers' copyright suit against Anthropic indicated Thursday that he thinks training its LLM with copyrighted works is fair use, but said plaintiffs can likely pursue claims that the AI startup infringed by obtaining those training materials from pirating websites instead of buying them.
-
May 22, 2025
Source Code Inventor Hits Wellness Tech Co. With IP Suit
The developer of source code that uses "structured energy patterns, photonic collision and dynamic linguistic displays" as a medical treatment accused a Las Vegas wellness technology company Thursday of infringing his code's copyright and reaping more than $100 million in sales as a result.
-
May 22, 2025
Fed. Circ. Backs Pfizer Win Against Gene Therapy Patents
The Federal Circuit on Thursday sided with the Patent Trial and Appeal Board's findings that a pair of patents covering a new kind of experimental gene therapy to treat hemophilia were invalid, handing a win to patent challenger Pfizer.
-
May 22, 2025
EscapeX Says No Further Sanctions Needed In Google Fight
EscapeX IP has said a New York federal court shouldn't sanction the company and its law firm, Ramey LLP, under its inherent power in a voluntarily dismissed patent infringement lawsuit against Google.
-
May 22, 2025
EpiPen Direct Buyers, Mylan Get Final OK On Antitrust Deal
Mylan Pharmaceuticals' $73.5 million settlement with a class of direct EpiPen buyers has received final approval from a Kansas federal judge, closing out claims from institutional drug resellers that Mylan worked with Pfizer to forestall an EpiPen generic from hitting the market and artificially inflating prices for the emergency injectable.
-
May 22, 2025
Rolex Accuses ATL Jewelers Of Knockoff Watch Sales
Luxury watchmaker Rolex filed a lawsuit Wednesday against two Atlanta jewelry stores, alleging the stores have violated Rolex's trademarks by restoring old second-hand watches with new bling and passing them off as genuine.
-
May 22, 2025
Isaac Hayes Estate Seeks Clarification In Trump Copyright Suit
The estate of deceased soul singer and songwriter Isaac Hayes and its related company asked a Georgia federal court on Thursday to clarify or reconsider its order dismissing several claims from their copyright infringement suit against President Donald Trump and his 2024 campaign.
-
May 22, 2025
Susman Godfrey Partner To Lead News Orgs In OpenAI MDL
A Susman Godfrey LLP heavy-hitter who helped orchestrate a $787 million settlement in Dominion Voting Systems' defamation suit against Fox News will lead news organizations in their potentially big-dollar copyright claims against Microsoft and OpenAI, a Manhattan federal judge heard Thursday.
-
May 22, 2025
Beastie Boys Settle 'Sabotage' IP Suit With Chili's Owner
The Beastie Boys have reached a settlement in their copyright infringement suit in New York federal court against Chili's owner Brinker International Inc., which was accused of using one of the rap group's songs, "Sabotage," in social media marketing without permission.
-
May 21, 2025
Steve Madden Alleges Adidas Is Trying To Monopolize Stripes
Steve Madden Ltd. on Wednesday hauled Adidas into New York federal court, saying it was "tired" of being targeted by the athletic apparel and footwear company for using elements it says bear no resemblance to the three parallel stripes donning Adidas products.
-
May 21, 2025
Squires Talks Fortress, PTAB Invalidations In Senate Hearing
The Trump administration's nominee for U.S. Patent and Trademark Office director had his moment before the Senate Judiciary Committee on Wednesday, where he downplayed his controversial connections to litigation finance giant Fortress Investment Group and raised concerns that too many bad patents were being issued.
-
May 21, 2025
9th Circ. Judge Asks If Apple's Watch Updates 'Ice Out' Rivals
Two Ninth Circuit judges appeared skeptical Wednesday of Apple Inc.'s arguments against reviving an antitrust suit brought by medical monitoring startup AliveCor Inc. after Apple blocked third-party access to medical data on the Apple Watch, with one judge asking rhetorically whether a "marginal" improvement by Apple could actually be a way to "ice out" competition.
-
May 21, 2025
Tesla Cites Nat'l Security In Bid To Keep PTAB Challenge Alive
Tesla Inc. has argued that "national security interests" support its Patent Trial and Appeal Board challenge to a digital camera patent that it's accused of infringing, urging the U.S. Patent and Trademark Office's acting director to reject the patent owner's bid to toss the challenge under new board procedures.
-
May 21, 2025
Albright Sends Patent Suit Against Amazon To Calif.
A Texas federal judge transferred a software company's patent infringement suit against Amazon and two affiliates to California federal court on Wednesday.
-
May 21, 2025
ITC To Eye Qualcomm, Nvidia Circuit Imports Over Onesta IP
The U.S. International Trade Commission will look into allegations over whether Qualcomm Inc., Nvidia Corp. and others are infringing several electronics patents by importing integrated circuits and electronics devices.
-
May 21, 2025
GOP FTC Renews Calls For Orange Book Patent Delistings
The now-Republican controlled Federal Trade Commission again called on Teva, Novartis, Mylan and other drugmakers to remove patents from a key federal database that partially insulates their drugs from generic competition, arguing Wednesday the patents cover "devices," not drugs, and thus don't warrant such protection.
-
May 21, 2025
DraftKings Denied 3rd Circ. Review In MLB Players' IP Case
A Pennsylvania judge on Wednesday denied a request from DraftKings Inc. to appeal to the Third Circuit the lower court's refusal to dismiss an intellectual property lawsuit that accuses the company of using players' images without permission, saying the issues raised are not appropriate for immediate appeal.
-
May 21, 2025
ITC Wants Full Fed. Circ. To Rehear Lashify Dispute
The U.S. International Trade Commission wants the Federal Circuit to rethink its finding that the commission was wrongly prohibiting domestic expenses related to sales, marketing and other activities from allowing companies to pursue ITC patent cases.
-
May 21, 2025
Country Music Singer Urges Sens. To Pass AI Deepfakes Bill
Country music star Martina McBride urged U.S. senators Wednesday to pass legislation aimed at protecting individuals from having their voice and likeness replicated with artificial intelligence without their permission, saying "it's frightening, and it's wrong."
-
May 21, 2025
USPTO Tackling Backlog Despite Hiring Freeze, Official Says
While the U.S. Patent and Trademark Office waits out a federal hiring freeze preventing it from bringing in more patent examiners, it's using initiatives like reassignments and rewards to "do more with less" and cut down on patent pendency, the agency's deputy commissioner for patents said Wednesday.
-
May 21, 2025
What To Know Before VLSI, Intel's Patent License Trial
Over the last several years, VLSI Technologies has racked up infringement awards in an expansive multibillion-dollar fight against Intel, but those could be rendered moot after a trial next week, when a Texas federal jury reviews a question central to determining whether Intel already has a license to VLSI's patents.
-
May 21, 2025
Dem Rep. Calls For Withdrawal Of New PTAB Denial Policies
A Democratic member of the U.S. House of Representatives representing Silicon Valley told the acting head of the U.S. Patent and Trademark Office that she had "serious concern" regarding new policy in which the director has the final word on whether patent challenges should be denied for discretionary reasons.
-
May 21, 2025
Innoscience Rips Bid To Undo PTAB Win In Chip IP Fight
Chinese company Innoscience has urged the acting head of the U.S. Patent and Trademark Office to shut down a California-based semiconductor company's bid to throw out a Patent Trial and Appeal Board decision invalidating one of its patents.
-
May 21, 2025
Full Fed. Circ. Undoes $20M Google Loss, Orders New Trial
The full Federal Circuit on Wednesday ordered a new damages trial in a case where a jury told Google LLC to pay $20 million for infringing an EcoFactor Inc. thermostat patent, ruling that the testimony of EcoFactor's damages expert was unreliable and should not have been admitted.
Expert Analysis
-
Tracking Changes To AI Evidence Under Federal Rules
As the first quarter of 2025 draws to a close, important changes to the Federal Rules of Evidence regarding the use of artificial intelligence in the courtroom are on the horizon, including how to handle evidence that is a product of machine learning, say attorneys at Debevoise.
-
Law Firm Executive Orders Create A Legal Ethics Minefield
Recent executive orders targeting BigLaw firms create ethical dilemmas — and raise the specter of civil or criminal liability — for the government attorneys tasked with implementing them and for the law firms that choose to make agreements with the administration, say attorneys at Buchalter.
-
Firms Must Embrace Alternative Billing Models Or Fall Behind
As artificial intelligence tools eliminate inefficiencies and the Big Four accounting firms enter the legal market, law firms that pivot from the entrenched billable hour model to outcomes-based pricing will see a distinct competitive advantage, says attorney William Brewer.
-
Key Issues To Watch As USPTO Changes Abound
As 2025 continues to unfold, changes at the U.S. Patent and Trademark Office — including new leadership, operational reforms, legislative initiatives and AI-related policies — have potential to influence proceedings, including efforts to prosecute patents and adversarial proceedings before the Patent Trial and Appeal Board, say attorneys at Morgan Lewis.
-
Trending At The PTAB: A Pivot On Discretionary Denials
Following the U.S. Patent and Trademark Office's rescission of the 2022 Vidal memorandum and a reversion to the standards under Apple v. Fintiv, petitioners hoping to avoid discretionary denials should undertake holistic review of all Fintiv factors, rather than relying on certain fail-safe provisions, say attorneys at Finnegan.
-
How Trump Policies Are Affecting The Right To Repair
Recent policy changes by the second Trump administration — ranging from deregulatory initiatives to tariff increases — are likely to have both positive and negative effects on the ability of independent repair shops and individual consumers to exercise their right to repair electronic devices, say attorneys at Carter Ledyard.
-
How Attorneys Can Master The Art Of On-Camera Presence
As attorneys are increasingly presented with on-camera opportunities, they can adapt their traditional legal skills for video contexts — such as virtual client meetings, marketing content or media interviews — by understanding the medium and making intentional adjustments, says Kerry Barrett.
-
Patent Drafting Pointers From Fed. Circ. COVID Test Ruling
The Federal Circuit's recent decision in DNA Genotek v. Spectrum Solutions provides several best practice pointers for drafting and prosecuting patent applications, highlighting how nuances in wording can potentially limit the scope of claims or otherwise affect claim constructions, says Irah Donner at Manatt.
-
Opinion
Congress Must Reform The PTAB To Protect Small Innovators
Lawmakers must reintroduce the Promoting and Respecting Economically Vital American Innovation Leadership Act or similar legislation to prevent larger companies from leveraging the Patent Trial and Appeal Board to target smaller patent holders, says Schwegman Lundberg's Russell Slifer, former deputy director of the U.S. Patent and Trademark Office.
-
Series
Baseball Fantasy Camp Makes Me A Better Lawyer
With six baseball fantasy experiences under my belt, I've learned time and again that I didn't make the wrong career choice, but I've also learned that baseball lessons are life lessons, and I'm a better lawyer for my time at St. Louis Cardinals fantasy camp, says Scott Felder at Wiley.
-
Series
Adapting To Private Practice: From Fed. Prosecutor To BigLaw
Making the jump from government to private practice is no small feat, but, based on my experience transitioning to a business-driven environment after 15 years as an assistant U.S. attorney, it can be incredibly rewarding and help you become a more versatile lawyer, says Michael Beckwith at Dickinson Wright.
-
Fed. Circ. In Feb.: Lessons On Cases With Many Patent Claims
The Federal Circuit's decision in Kroy IP v. Groupon last month establishes that inter partes review petitioners cannot rely on collateral estoppel to invalidate patent claims after challenging a smaller subset, highlighting the benefit that patent owners may gain from seeking patents with many claims, say attorneys at Knobbe Martens.
-
Firms Still Have Lateral Market Advantage, But Risks Persist
Partner and associate mobility data from the fourth quarter of 2024 shows that we’re in a new, stable era of lateral hiring where firms have the edge, but leaders should proceed cautiously, looking beyond expected revenue and compensation analyses for potential risks, say Julie Henson and Greg Hamman at Decipher Investigative Intelligence.
-
The New Playbook For Managing Athlete-Controlled IP
Comparing Luka Dončić's and Lebron James' approaches to establishing and managing their brands highlights a shift toward athlete-controlled IP and some lessons on how players and teams can collaborate to capitalize on athletes' star power, say attorneys at Debevoise.
-
Opinion
We Must Allow Judges To Use Their Independent Judgment
As two recent cases show, the ability of judges to access their independent judgment crucially enables courts to exercise the discretion needed to reach the right outcome based on the unique facts within the law, says John Siffert at Lankler Siffert & Wohl.